An interventional study of Antenatal Education Class and Anaemia Awareness Brochure in Anemia, Iron-Deficiency, Anemia in Pregnancy and Pregnancy, sponsored by Sakarya University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Sakarya University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Anemia, Iron-Deficiency with a site in Turkey — none open to participants now, none under way, none of them phase 3. Anemia, Iron-Deficiency · Turkey.
Among the 13 studies in Anemia, Iron-Deficiency with a site in Turkey, this one is one of 4 that started in 2022, is one of 6 with no phase, and was the 13th registered.
602 studies on the registry are indexed under Anemia, Iron-Deficiency; 93 are open to participants now.
Browse Anemia, Iron-Deficiency studies →None of the 13 studies in Anemia, Iron-Deficiency with a site in Turkey is open now. The open studies under Anemia, Iron-Deficiency, anywhere →
Of the 52 Anemia, Iron-Deficiency studies recruiting now, 18 (35%) set no upper age limit and 30 (58%) stop at 75 or younger; 16 take children under 18; 15 take healthy volunteers.
This study: 18 Years to 45 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 4 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 195 is above the median of 100 across 461 interventional studies indexed under Anemia, Iron-Deficiency.
Median enrollment 195 across the 7 interventional studies, 369 across the 5 observational. Of the 10 that completed or were terminated, 1 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 13 have an industry lead sponsor. The 10 most frequent:
Sakarya University is the lead sponsor of 191 studies on the registry; 53 are open to participants now.
Sakarya University has 1 study filed under Anemia, Iron-Deficiency — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Anemia, Iron-Deficiency with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Anaemia is common in pregnancy and can cause problems for both the mother and the baby. Iron tablets are an effective treatment, but many pregnant women do not take them regularly. Reasons include forgetfulness, side effects, and limited knowledge about anaemia.
This randomized controlled study evaluated whether giving pregnant women additional education about anaemia, on top of routine prenatal care, improves their awareness of anaemia, their regular use of iron supplements, and their haemoglobin levels.
Pregnant women aged 18 to 45 years, between 16 and 34 weeks of pregnancy and diagnosed with anaemia, were randomly assigned to one of three groups:
Group 1: routine information + an anaemia awareness brochure + an antenatal education class Group 2: routine information + an anaemia awareness brochure only Group 3 (control): routine information only
Anaemia awareness, iron supplement use, and haemoglobin levels were assessed at the start of the study and after 4 weeks. Haemoglobin levels after delivery were also recorded.
The main question of the study was whether haemoglobin levels after 4 weeks differ among the three groups. The study also examined whether education and brochures increase women's knowledge about anaemia and help them take iron supplements more regularly.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Hemoglobin (Hb)
The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Pregnant women with anaemia received routine prenatal information plus an anaemia awareness brochure and a face-to-face antenatal education class. The class and brochure covered the definition, causes, symptoms, maternal and fetal risks, and prevention of anaemia, iron-rich nutrition, and the correct use of oral iron supplements.
Behavioral: Antenatal Education Class · Behavioral: Anaemia Awareness Brochure · Other: Routine Prenatal Care
Pregnant women with anaemia received routine prenatal information plus an anaemia awareness brochure covering anaemia in pregnancy, its risks, iron-rich foods, and the correct use of oral iron supplements. No education class was provided.
Behavioral: Anaemia Awareness Brochure · Other: Routine Prenatal Care
Pregnant women with anaemia received only routine prenatal information and care as provided in standard practice, without the brochure or education class.
Other: Routine Prenatal Care
A face-to-face group education class for pregnant women with anaemia, delivered in addition to routine prenatal care. The class covered the definition, causes, symptoms, and maternal and fetal risks of anaemia in pregnancy, its prevention, iron-rich nutrition, factors affecting iron absorption, and the correct use of oral iron supplements, including timing, possible side effects, and the importance of daily use. Participants in this arm also received the anaemia awareness brochure.
A printed brochure prepared by the researchers, given to participants in addition to routine prenatal care. The brochure provided information on anaemia in pregnancy, its risks for mother and baby, iron-rich foods, factors affecting iron absorption, and how to take oral iron supplements correctly and regularly.
Standard routine prenatal information and care provided as usual practice, without additional brochure or education class.
Haemoglobin Level at 4 Weeks
Haemoglobin concentration (g/dL) will be measured by complete blood count at baseline and at the end of week 4. Post-intervention haemoglobin levels will be compared among three groups: Experimental 1 (routine counselling + anaemia awareness brochure + antenatal education class), Experimental 2 (routine counselling + brochure only), and Control (routine counselling only). The comparison will use analysis of covariance (ANCOVA) adjusted for baseline haemoglobin.
Time frame: Baseline and 4 weeks after enrollment
Change in Anaemia Awareness Score
Anaemia awareness will be assessed using a structured questionnaire covering the definition, causes, symptoms, maternal and fetal risks, prevention, and iron-rich nutrition. Higher scores indicate greater awareness. Within-group change and between-group differences in post-intervention scores will be evaluated.
Time frame: Baseline and 4 weeks after enrollment
Adherence to Oral Iron Supplementation
Adherence to prescribed oral iron supplementation will be assessed by self-report.. The proportion of participants taking iron supplements every day will be compared within and between groups.
Time frame: Baseline and 4 weeks after enrollment
Plan to share: Yes — De-identified individual participant data underlying the results reported in the article (demographic characteristics, haemoglobin values, anaemia awareness scores, and iron supplement use data) will be shared.
Supporting information: Study protocol
Time frame: Data will be available beginning 6 months after publication of the article and ending 5 years after publication.
Access criteria: Data will be shared with researchers who provide a methodologically sound proposal, upon reasonable request to the corresponding author. Data will be shared in accordance with the Turkish Personal Data Protection Law (KVKK) and after approval of the proposal by the study investigators. A data sharing agreement may be required.
No publications or documents are linked to this record.
Ran from Jan 2022 to primary completion in Dec 2025, 47 months.
Of 133 non-industry interventional studies with no phase under Anemia, Iron-Deficiency, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's 47 months is above that.
Counting every sponsor, half of 142 studies reached it within 11 months; a quarter within 3 and three quarters within 21.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.